DJIA 17,719.92 -78.57 -0.44%
NASDAQ 5,108.67 -18.86 -0.37%
S&P 500 2,080.41 -9.70 -0.46%
market minute promo

Gilead Sciences (NASDAQ: GILD)

105.96 -2.04 (-1.89%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GILD $105.96 -1.89%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $108.21
Previous Close $108.00
Daily Range $105.69 - $108.31
52-Week Range $85.95 - $123.37
Market Cap $152.7B
P/E Ratio 9.91
Dividend (Yield) $1.72 (1.6%)
Ex-Dividend Date
Dividend Pay Date
Volume 9,834,903
Average Daily Volume 9,420,680
Current FY EPS $11.96




Drug Makers

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website:

News & Commentary Rss Feed

There's a 0.0000000000028% Chance This Drug Doesn't Work

Statistics favor Gilead Sciences' Zydelig by a wee bit.

Julian Robertson Trims, Santander Consumer, NVIDIA

Cytodyne's PRO 140: Better Safety, Non-Inferior Efficacy In HIV

Where Will Gilead Sciences Be in 10 Years?

Gilead Sciences has been a terrific stock to hold over the past 10 years, but what will this company look like a decade from now?

Gilead's HCV Sales May Have Peaked

The Most Important Message From Charlie Sheen's Recent HIV Admission

Charlie Sheen stunned the world with his HIV admission, but there's a far bigger lesson behind this announcement.

3 Healthcare Stocks With Massive Buyback Programs

These company's are spending billions of dollars repurchasing their shares, and that may not be a bad thing.

Stock Market News for November 27, 2015

The Zacks Analyst Blog Highlights: BioMarin, Amgen, Vertex, Gilead, Biogen and Repros

Giving Thanks, Healthcare Style

Giving thanks and recognizing the heroes of the healthcare industry.

See More GILD News...

GILD's Top Competitors

GILD $105.96 (-1.89%)
Current stock: GILD
AMGN $161.10 (-1.48%)
Current stock: AMGN
CELG $109.45 (-2.88%)
Current stock: CELG
$0.00 (0.00%)
Current stock: